Cargando…
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects
SIMPLE SUMMARY: Pancreatic neuroendocrine tumors (PanNETs) are often diagnosed when advanced or metastatic, and at this stage curative surgery in no longer an option. Given that available treatments for advanced disease have shown limited efficacy, novel therapies are urgently needed. In this scenar...
Autores principales: | Gulde, Sebastian, Foscarini, Alessia, April-Monn, Simon L., Genio, Edoardo, Marangelo, Alessandro, Satam, Swapna, Helbling, Daniel, Falconi, Massimo, Toledo, Rodrigo A., Schrader, Jörg, Perren, Aurel, Marinoni, Ilaria, Pellegata, Natalia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688197/ https://www.ncbi.nlm.nih.gov/pubmed/36428573 http://dx.doi.org/10.3390/cancers14225481 |
Ejemplares similares
-
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
por: April-Monn, Simon Leonhard, et al.
Publicado: (2021) -
Update on Histological Reporting Changes in Neuroendocrine Neoplasms
por: Bräutigam, Konstantin, et al.
Publicado: (2021) -
Functional Imaging of Pheochromocytoma with (68)Ga-DOTATOC and (68)C-HED in a Genetically Defined Rat Model of Multiple Endocrine Neoplasia
por: Miederer, Matthias, et al.
Publicado: (2011) -
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications
por: Marinoni, Beatrice, et al.
Publicado: (2014) -
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
por: Di Domenico, Annunziata, et al.
Publicado: (2020)